Who is sponsoring CALYPSO?

CALYPSO is sponsored by Duke University.

What condition does CALYPSO study?

CALYPSO studies Ventricular Tachycardia.

What drugs are being tested in CALYPSO?

Interventions: amiodarone, sotalol, Biosense Webster's NAVI-STAR Thermo-Cool.

What is the status of CALYPSO?

CALYPSO is currently TERMINATED.

Last reviewed 2014-10-06 · How we verify

Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator (CALYPSO) PILOT TRIAL

NCT01576042 NA TERMINATED Results posted

The purpose of this pilot trial is to determine the feasibility of a large, multi-center randomized clinical trial aimed to test whether a treatment strategy of percutaneous catheter ablation of ventricular tachycardia (VT) is superior to state-of-the-art pharmacologic therapy at reducing all-cause mortality in patients with an implantable cardioverter defibrillator (ICD) who receive therapy for VT in the absence of any reversible cause.

Details

Lead sponsor	Duke University
Phase	NA
Status	TERMINATED
Enrolment	27
Start date	2012-05
Completion	2014-05

Conditions

Ventricular Tachycardia

Interventions

amiodarone
sotalol
Biosense Webster's NAVI-STAR Thermo-Cool

Primary outcomes

Number of Participants Completed Month 3 Follow-Up — 3 months
Records participants who completed Month 3 Follow-Up Visit

Countries

United States